<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> following <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> is known to contribute to injury </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase (NOX) is a major enzyme system originally studied in immune cells that leads to <z:chebi fb="1" ids="18421">superoxide</z:chebi> (O.*) generation </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="2781">Apocynin</z:chebi> is a NOX inhibitor that has been studied as a potential treatment in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we explored the effect of different doses of <z:chebi fb="0" ids="2781">apocynin</z:chebi> in a mouse model of 2 h transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) followed by 22 h reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="2781">Apocynin</z:chebi>, given i.v. at a dose of 2.5 mg/kg 30 min before reperfusion, improved neurological function (P&lt;0.01), reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (P&lt;0.05), and reduced the incidence of <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> (P&lt;0.05), but not at higher doses of 3.75 and 5 mg/kg, where it actually increased brain <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="2781">Apocynin</z:chebi> also tended to reduce mortality at the lower dose, but not at higher doses </plain></SENT>
<SENT sid="6" pm="."><plain>Using hydroethine fluorescence to delineate O.* in the brain, neurons and some microglia/macrophages, but not vascular endothelial cells were found to contain O.* </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="2781">Apocynin</z:chebi> at protective doses markedly prevented <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increases in O.* </plain></SENT>
<SENT sid="8" pm="."><plain>Our data suggested that <z:chebi fb="0" ids="2781">apocynin</z:chebi> can protect against experimental <z:hpo ids='HP_0001297'>stroke</z:hpo>, but with a narrow therapeutic window </plain></SENT>
</text></document>